86. Which one of the following sets of protein factors, named as Yamanaka factors, can be used to convert
mammalian somatic cells into induced pluripotent stem cells?
(1) Oct3/4, Sox2, Klf4, c-Myc
(2) c-fos, nestin, TGF, c-jun
(3) Oct3, snail, FGF, nanos
(4) Hstf, vimentin, ets, ras

---

Introduction:

The field of stem cell research has seen remarkable advances over the years, with one of the most notable breakthroughs being the creation of induced pluripotent stem cells (iPSCs). These cells are generated by reprogramming somatic cells (like skin or blood cells) into a pluripotent state, meaning they have the potential to differentiate into almost any type of cell in the body. This transformative process was made possible by a set of proteins known as the Yamanaka factors, which have revolutionized regenerative medicine, personalized therapies, and disease modeling. In this article, we will explore what the Yamanaka factors are, how they work, and their significance in stem cell research.

---

What Are Yamanaka Factors?

The Yamanaka factors refer to a specific set of four transcription factors that can induce the reprogramming of somatic cells into induced pluripotent stem cells (iPSCs). These factors were first discovered by Japanese researcher Shinya Yamanaka in 2006, who demonstrated that by introducing just four genes into somatic cells, they could be reprogrammed to resemble embryonic stem cells. The four factors are:

1. Oct3/4

2. Sox2

3. Klf4

4. c-Myc

These transcription factors work together to activate pluripotency genes and silence genes associated with somatic cell identity, effectively resetting the cell’s developmental potential.

---

How Do Yamanaka Factors Work?

Each of the Yamanaka factors plays a critical role in the reprogramming process:

• Oct3/4: This factor is essential for maintaining the pluripotency of stem cells. It activates key genes involved in stem cell self-renewal and represses genes that drive differentiation into specialized cell types.

• Sox2: Sox2 works in tandem with Oct3/4 to maintain pluripotency and prevent differentiation. It is crucial for the early stages of reprogramming.

• Klf4: Klf4 promotes the expression of genes that prevent the differentiation of cells. It also works to inhibit the p53 pathway, which would otherwise trigger cell death during the reprogramming process.

• c-Myc: This factor helps to enhance the reprogramming efficiency by promoting cell proliferation and enabling the cell to bypass certain growth control checkpoints.

When these four transcription factors are introduced into somatic cells, they activate the pluripotency network and reprogram the cells back to a pluripotent state.

---

Applications of Induced Pluripotent Stem Cells (iPSCs)

The discovery of iPSCs has had significant implications in various areas of research:

1. Regenerative Medicine: iPSCs can be differentiated into any type of cell, making them an invaluable resource for regenerative therapies. For example, they hold potential for treating degenerative diseases such as Parkinson’s disease or spinal cord injuries.

2. Disease Modeling: iPSCs derived from patients with specific diseases can be used to create disease models. These models help scientists study the underlying mechanisms of diseases and test potential therapies.

3. Personalized Medicine: By generating iPSCs from individual patients, researchers can develop personalized treatments tailored to the specific genetic makeup and needs of each patient.

---

Which Set of Factors is Correct?

The correct set of proteins, known as Yamanaka factors, required to reprogram mammalian somatic cells into iPSCs is:

• Oct3/4

• Sox2

• Klf4

• c-Myc

These four factors are directly involved in reprogramming somatic cells into pluripotent stem cells, as demonstrated by Yamanaka’s ground breaking research.

---

Conclusion:

The discovery of the Yamanaka factors has fundamentally changed the field of stem cell biology. By introducing just four transcription factors into somatic cells, researchers can reprogram them into induced pluripotent stem cells (iPSCs), unlocking new possibilities in medicine, disease modeling, and personalized therapies. The Yamanaka factors – Oct3/4, Sox2, Klf4, and c-Myc – are key to this transformation, making them indispensable tools in the field of regenerative medicine.

---

Final Answer: The correct set of Yamanaka factors that are used to convert mammalian somatic cells into induced pluripotent stem cells is Oct3/4, Sox2, Klf4, and c-Myc.

---

Related Keywords: Yamanaka factors, induced pluripotent stem cells, somatic cell reprogramming, Oct3/4, Sox2, Klf4, c-Myc, pluripotency, stem cell research.